Previous close | 1.7500 |
Open | 1.7500 |
Bid | 1.7600 x 1800 |
Ask | 1.8500 x 800 |
Day's range | 1.7500 - 1.7650 |
52-week range | 1.6800 - 4.0000 |
Volume | |
Avg. volume | 24,733 |
Market cap | 92.824M |
Beta (5Y monthly) | 0.38 |
PE ratio (TTM) | 3.83 |
EPS (TTM) | 0.4600 |
Earnings date | 19 Jun 2024 - 24 Jun 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 27 Mar 2024 |
1y target est | N/A |
iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced that it filed its annual report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission on April 25, 2024. The annual report on Form 20-F is available on the Company's investor relations website at https://ir.ihuman.com/. iHuman will provide a hard copy of its annual report on Form 20-F containing complete a
iHuman ( NYSE:IH ) Full Year 2023 Results Key Financial Results Revenue: CN¥1.02b (up 3.3% from FY 2022). Net income...
iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023.